Klinischer Newsletter

    Klinischer Newsletter

    Für regelmmäßige Updates zu unseren neusten Studien:

    Jetzt Anmelden

    Publikationssuche

    Unsere Forschungs- und Entwicklungsteams sind weltweit im Einsatz und generieren Synergien aus unserem Expertenwissen und verwandten Fachdisziplinen. Wir stehen im internationalen Austausch mit unabhängigen Fachinstitutionen, Key Opinion Leadern und Multiplikatoren, um so Kooperations- und Wissensmanagement auf höchstem Niveau gewährleisten zu können. Im Rahmen dessen führen wir umfangreiche Forschungen durch, die kontinuierlich auf Kongressen in Form von Postern oder freien Vorträgen unserer Kooperationspartner sowie in Symposien und Workshops präsentiert und in namhaften wissenschaftlichen Fachzeitschriften veröffentlicht werden. Die größtenteils von unabhängigen Gutachtern bewerteten, evidenzbasierten Fachpublikationen, stellen wir Ihnen in dieser Datenbank zur Verfügung:

    1. Poster

      Safety and efficacy of a monofilament fibre pad for superficial debridement prior to photodynamic therapy: a review of 20 cases

      Poster presented at BDNG Annual Conference 2016 21.06.2016 Bournemouth, UK
      Products Debrisoft Pad
    2. Poster

      Science and Clinical Practice: Supporting patient care for leg ulcers

      Poster presented at EWMA 2016 11.05.2016 Bremen, Germany
      Products Rosidal K
    3. Poster

      All patients deserve the right to appropriate care

      Poster presented at EWMA 2016 11.05.2016 Bremen, Germany
      Products Rosidal K
    4. Poster

      MANAGING LYMPHORRHEA IN ADVANCED HEART FAILURE ON A PATIENT WITH AN UNDERLYING PRIMARY LYMPHOEDEMA WITH A TWO-COMPONENT BANDAGE SYSTEM

      Poster presented at EWMA 2016 11.05.2016 Bremen, Germany
      Products Rosidal TCS
    5. Poster

      Novel uses for Debrisoft in burns and scars

      Poster presented at British Burn Association 2016 11.05.2016 Newcastle, United Kingdom

      This poster demonstrates the novel use of Debrisoft, a monofilament fibre debridement pad consisting of 18 million polyester fibres. These are a specific angle, length and density that allow them to reach uneven areas and loosen, lift and bind into the pad necrotic tissue, hyperkeratotic skin, and adherent exudate from the wound and surrounding skin. The pad is soft, flexible and comfortable which allows for non-traumatic debridement and cleansing.

    6. Poster

      IN VITRO COMPARISON OF THE DEBRIDEMENT PERFORMANCE OF TWO DEBRIDER DEVICES

      Poster presented at EWMA 2016 11.05.2016 Bremen, Germany
      Products Debrisoft Pad
      Further languages
    7. Poster

      Use of a Novel Device for Selective Mechanical Debridement of Chronic Wounds

      Poster presented at EWMA 2016 11.05.2016 Bremen, Germany
    8. Poster

      Comparative evaluation of a monofilament fibre debridement pad and a pre-moistened debridement cloth

      Poster presented at EWMA 2016 11.05.2016 Bremen, Germany

      Aim:

      To compare the efficacy of 2 products in managing slough and hyperkeratosis. Outcome measures included visible effect, treatment time, patient and clinician feedback.

       

      Method:

      Patients with lower limb wounds and hyperkeratosis were treated in a wound clinic with either a debridement pad or a debridement cloth. Outcomes were recorded over 3-weeks. Continuing treatment plans were documented at week 4.

       

      Results / Discussion:

      Using the debridement pad clinicians noted an immediate removal of slough/hyperkeratosis along with a ’deep clean’ effect in all cases. Clinicians felt a smaller option would be useful for some wounds. Clinicians remarked on a ’film’ or ’froth’ left in the wound/limb with the debridement cloth. A difficulty with getting into deeper areas of the wound was also noted. 1 patient did express willingness to continue with the product and reported ease of use. In response to the initial results, clinical evidence and NICE guidance, the decision was made to stop the evaluation and include debridement pads on the woundcare formularly.

       

      Conclusion:

      Whilst there was some improvement reported with the use of a debridement cloth, there was a visible imporvement for all cases with the debridement pad. This has led to improved patient satisfaction, influenced clinical practice and formulary inclusion.

      Products Debrisoft Pad
    9. Poster

      A holistic approach to chronic oedema management

      Poster presented at EWMA 2016 11.05.2016 Bremen, Germany

      Aim:

      To report positive outcomes from the management of a complex case of chronic oedema. Highlighting the importance of biofilm management and specialist bandage techniques.

       

      Method:

      Upon assessment, the patient had received compression therapy for over 15 years. Daily bandage reapplication had been ongoing for 3 years. Pain score upon assessment 10/10.

       

      Results / Discussion:

      This approach has involved partnership from a varied skill mix within the team, including healthcare assistants and tissue viability specialists. This and the reduction of visits has enabled cost minimisation and improved clinical outcomes. The patient’s has an increased self-esteem and feels able to now interact socially, improving her quality of life.

       

      Conclusion:

      Chronic oedema management invoving a partnership approach, utilising skin-care and specialist bandage techniques can improve clinical outcomes, reduce costs and improve quality of life.

      Products Debrisoft Pad
    10. Poster

      BENEFITS OF COMMON INSTRUCTIONS IN DEBRIDEMENT OF WOUNDS WITH A FIBRE DEBRIDEMENT PAD

      Poster presented at EWMA 2016 11.05.2016 Bremen, Germany
      Products Debrisoft Pad